Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Anticancer Research|September 29, 2023
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)Tomohiro Tamura, Takeshi Numata, Hidetoshi Yanai, et al.
In Vivo (Athens, Greece)|August 31, 2023
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)Shinichiro Okauchi, Gen Ohara, Toshihiro Shiozawa, et al.
Anticancer Research|April 30, 2022
Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR-mutated Non-small Cell Lung CancerToshihiro Shiozawa, Takeshi Numata, Tomohiro Tamura, et al.
In Vivo (Athens, Greece)|July 2, 2020
Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant MetastasisTakeshi Numata, Takeo Endo, Hidetoshi Yanai, et al.
Oncology Letters|February 20, 2013
Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancerTakayuki Kaburagi, Hiroaki Satoh, Kenji Hayashihara, et al.
Medical Oncology (Northwood, London, England)|November 3, 2012
Bevacizumab-containing chemotherapy for non-small cell lung cancer patients: a population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research groupHiroyuki Nakamura, Hiroaki Satoh, Takayuki Kaburagi, et al.
In Vivo (Athens, Greece)|July 2, 2020
Clinicopathological Features in Elderly ALK-rearranged Non-small Cell Lung Cancer PatientsKunihiko Miyazaki, Shinya Sato, Takahide Kodama, et al.
Molecular and Clinical Oncology|March 21, 2014
Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research GroupKoichi Kurishima, Hiroaki Satoh, Takayuki Kaburagi, et al.
Anticancer Research|September 29, 2020
Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical PracticeYutaka Yamada, Tomohiro Tamura, Yusuke Yamamoto, et al.
Pageof 9